HIV stigma and missed medications in HIV-positive people in five african countries

AIDS Patient Care and STDs

Volumn 23, Issue 5, 2009, Pages 377-387

  Dlamini, Priscilla S ^a   Wantland, Dean ^b   Makoae, Lucy N ^c   Chirwa, Maureen ^d   Kohi, Thecla W ^e   Greeff, Minrie ^f   Naidoo, Joanne ^g   Mullan, Joseph ^b   Uys, Leana R ^g   Holzemer, William L ^b  

^a UNIVERSITY OF SWAZILAND   (Swaziland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL UNIVERSITY OF LESOTHO   (Lesotho)

^d UNIVERSITY OF MALAWI   (Malawi)

^e MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^f NORTH WEST UNIVERSITY   (South Africa)

^g UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LESOTHO; MAJOR CLINICAL STUDY; MALAWI; MALE; PATIENT COMPLIANCE; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT; SOUTH AFRICA; STIGMA; SWAZILAND; TANZANIA;

ADOLESCENT; ADULT; AFRICA, SOUTHERN; AGED; ANTI-HIV AGENTS; ATTITUDE OF HEALTH PERSONNEL; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; QUALITY OF LIFE; QUESTIONNAIRES; STEREOTYPING; TANZANIA; YOUNG ADULT;

EID: 66749191666     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2008.0164     Document Type: Article

References (37)

1. Avert. HIV & AIDS in Africa. www.avert.org/aafrica.htm (Last accessed June 12, 2008).
2. Bangsberg DR, Hecht FM, Clague H, et al. Provider assessment of adherence to HIV antiretroviral therapy. J Acquir Immune Defic Syndr 2001;26:435-442.
3. Cohn SE, Kammann E, Williams P, Currier JS, Chesney MA. Association of adherence to Mycobacterium avium complex prophylaxis and antiretroviral therapy with clinical outcomes in Acquired Immunodeficiency Syndrome. Clin Infect Dis 2002;34:1129-1136.
4. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30.
5. Bangsberg DR. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis 2006;43:939-941.
6. Mills EJ, Nachega JB, Buchan I, et al. Adherence to anti-retroviral therapy in sub-Saharan Africa and North America: A meta-analysis. JAMA 2006;296:679-690.
7. Rintamaki LS, Davis TC, Skripkauskas S, Bennett CL, Wolf MS. Social stigma concerns and HIV medication adherence. AIDS Patient Care STDs 2006;20:359-368.
8. Rao D, Kekwaletswe TC, Hosek S, Martinez J, Rodriguez F. Stigma and social barriers to medication adherence with urban youth living with HIV. AIDS Care 2007;19:28-33.
9. Medley A, Garcia-Moreno C, McGill S, Maman S. Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: Implications for prevention of mother-to-child transmission programmes. Bull World Health Organ 2004;82:299-307.
10. Varga CA, Sherman GG, Jones SA. HIV-disclosure in the context of vertical transmission: HIV-positive mothers in Johannesburg, South Africa. AIDS Care 2006;18:952-960.
11. Daftary A, Padayatchi N, Padilla M. HIV testing and disclosure: A qualitative analysis of TB patients in South Africa. AIDS Care 2007;19:572-577.
12. Wood K, Chase E, Aggleton P. 'Telling the truth is the best thing': Teenage orphans' experiences of parental AIDS-related illness and bereavement in Zimbabwe. Soc Sci Med 2006;63:1923-1933.
13. Goffman E. Stigma: Notes on the Management of Spoiled Identity. Englewood Cliffs, NJ: Prentice Hall, 1963.
14. Alonzo AA, Reynolds NR. Stigma, HIV and AIDS: An exploration and elaboration of a stigma trajectory. Soc Sci Med 1995;41:303-315.
15. Holzemer WL, Uys L, Makoae L, et al. A conceptual model of HIV/AIDS stigma from five African countries. J Adv Nurs 2007;58:541-551.
16. Ware NC, Wyatt MA, Bangsberg DR. Examining theoretic models of adherence for validity in resource-limited settings. A heuristic approach. J Acquir Immune Defic Syndr 2006; 43(Suppl 1):S18-22.
17. Nachega JB, Hislop M, Dowdy DW, et al. Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr 2006;43:78-84.
18. Wolfe WR, Weiser SD, Bangsberg DR, et al. Effects of HIV-related stigma among an early sample of patients receiving antiretroviral therapy in Botswana. AIDS Care 2006;18:931-933.
19. Nachega JB, Stein DM, Lehman DA, et al. Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa. AIDS Res Hum Retroviruses. Oct 2004;20:1053-1056.
20. Weiser S, Wolfe W, Bangsberg D, et al. Barriers to antire-troviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr 2003;34: 281-288.
21. Uys LR, Chirwa M, Dlamini P, et al. Eating plastic, winning the lotto, joining the WWW: Descriptions of HIV/AIDS in Africa. J Assoc Nurses AIDS Care 2005;16:11-21.
22. Kohi T, Makoae L, Chirwa M, et al. HIV and AIDS stigma violates human rights in five African countries. Nurs Ethics 2006;13:405-414.
23. Naidoo J, Uys L, Greeff M, et al. Urban and rural differences in HIV/AIDS stigma in five African countries. Afr J AIDS Res 2007;6:17-23.
24. Holzemer WL, Uys LR, Chirwa ML, et al. Validation of the HIV/AIDS Stigma Instrument-PLWA (HASI-P). AIDS Care 2007;19:1002-1012.
25. Dlamini PS, Kohi TW, Uys LR, et al. Verbal and physical abuse and neglect as manifestations of HIV/AIDS stigma in five African countries. Public Health Nurs 2007;24:389-399.
26. Greeff M, Phetlhu R. The meaning and effect of HIV/AIDS stigma for people living with AIDS and nurses involved in their care in the North West Province, South Africa. Cur-ationis 2007;30:12-23.
27. Greeff M, Phetlhu R, Makoae LN, et al. Disclosure of HIV status: experiences and perceptions of persons living with HIV/AIDS and nurses involved in their care in Africa. Qual Health Res 2008;18:311-324.
28. Makoae LN, Greeff M, Phetlhu RD, et al. Coping with HIV-related stigma in five African countries. J Assoc Nurses AIDS Care 2008;19:137-146.
29. Uys LR, Holzemer WL, Chirwa ML, et al. The development and validation of the HIV/AIDS Stigma Instrument-Nurse (HASI-N). AIDS Care 2009;21:150-159.
30. Holmes WC, Shea JA. A new HIV/AIDS-targeted quality of life (HAT-QoL) instrument: Development, reliability, and validity. Med Care 1998;36:138-154.
31. Holmes WC, Shea JA. Two approaches to measuring quality of life in the HIV/AIDS population: HAT-QoL and MOS-HIV. Qual Life Res 1999;8:515-527.
32. Holzemer WL, Hudson A, Kirksey KM, Hamilton MJ, Bak-ken S. The Revised Sign and Symptom Check-List for HIV (SSC-HIVrev). J Assoc Nurses AIDS Care 2001;12:60-70.
33. Phaladze NA, Human S, Dlamini SB, et al. Quality of life and the concept of "living well" with HIV/AIDS in sub-Saharan Africa. J Nurs Scholarsh 2005;37:120-126.
34. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 2000;12:255-266.
35. Holzemer WL, Bakken S, Portillo CJ, et al. Testing a nurse-tailored HIV medication adherence intervention. Nurs Res 2006;55:189-197.
36. Singer J, Willett J. Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. New York: Oxford University Press, 2003.
37. Edwards L. Perceived social support and HIV/AIDS medication adherence among African American women. Qual Health Res 2006;16:679-691.